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ABSTRACT By light microscopic immunocytochemistry it
has been previously shown that P7% of the neurons in rat
dorsal root ganglia are labeled with an antiserum for glutamate
conjugated to hemocyanin; the smaller among these neurons
are also positive for substance P. By using a postembedding
ImmunoGold method and electron microscopy, it is shown here
that synaptic terminals in the superficial laminae of the spinal
cord of rats selectively stain for the same glutamate antiserum.
Immunolabeling is in small dome-shaped and in large scalloped
synaptic terminals. Scalloped terminals are of two types. One
type consists of dark terminals with many agranular vesicles of
different size and a few large granular vesicles; these are
probably endings of unmyelinated and small myelinated pri-
mary afferent fibers. The other type consists of light terminals
with small agranular vesicles homogeneous in size with neu-
rofilaments and many mitochondria; these are probably end-
ings of larger myelinated primary afferent fibers. By means of
double-labeling electron microscopic immunocytochemistry
with colloidal gold particles of two different sizes, it is also
shown here that substance P is present in only the dark type of
glutamate-labeled scalloped terminals. The primary afferent
origin ofthe terminals labeled by the antisera for glutamate and
for substance P is demonstrated by a triple-labeling strategy:
immunocytochemistry for both antisera on sections from rats
in which dorsal rhizotomy or dorsal root ganglion injection of
horseradish peroxidase conjugated to wheat germ agglutinin
was performed. It is proposed that glutamate is the neuro-
transmitter in primary afferents mediating input from differ-
ent peripheral receptor classes, including nociceptors. Effects
of glutamate and substance P on spinal dorsal horn neurons
may result from co-release of these two mediators from the
same dorsal root afferent terminal.
Glutamate meets several criteria as neurotransmitter in at
least some dorsal root ganglion (DRG) neurons. Dorsal roots
contain more glutamate than ventral roots (1, 2); reversal
potential of iontophoretically applied glutamate and synap-
tically evoked responses are similar in spinal neurons (3, 4);
and glutamate is released upon dorsal root stimulation in
spinal cord slices (5, 6). Furthermore, D-aspartate, a meta-
bolically inert analogue taken up by the same high-affinity
mechanisms as glutamate, selectively labels a fraction of
DRG neurons (7, 8), and its uptake and release is decreased
in the spinal cord of guinea pigs after dorsal rhizotomy (9).
Substance P (SP) is also probably associated with the
mediation of peripheral input to spinal dorsal horn neurons.
This peptide is present in a subpopulation of DRG neurons
and in numerous terminals in the superficial laminae of the
spinal dorsal horn (10, 11); it depolarizes dorsal horn neurons
activated by cutaneous stimulation when applied iontopho-
retically, and it is depleted by chronic deafferentation (12-
14). In the DRGs of the rat, up to 70% of the neurons are
labeled with an antiserum for a glutamate-hemocyanin con-
jugate, and most of the SP-positive DRG neurons are also
immunopositive for the conjugate (15).
The presence of high levels of glutamate in DRG perikarya
is suggestive of glutamergic transmission in primary afferent
fibers; however, more direct evidence of a neurotransmitter
role for this amino acid in these afferents would require its
presence in primary afferent endings in the spinal dorsal
horn. The present electron microscopic immunocytochemi-
cal study was undertaken for this purpose. A postembedding
colloidal gold approach was chosen to verify, also, whether
both glutamate and SP are present in the same dorsal root
terminal, as might be expected from their colocalization in
DRG neurons (15).
MATERIALS AND METHODS
Eight male Sprague-Dawley rats (250 g) anesthetized with
chloralhydrate were perfused transcardially with a mixture of
4% paraformaldehyde/0.2% picric acid/1.0% glutaralde-
hyde. Cervical cord segments were dissected and immersed
in the same fixative for several hours at 40C. Vibratome
sections (50 1Lm thick) of these segments were wafer-
embedded in Epon after immersion in 0.5% OS04. Thin
sections from samples of the superficial laminae of the dorsal
horn were collected on parlodion-coated slot nickel grids and
etched for 30 min with a saturated solution of sodium
metaperiodate, followed by 1% sodium borohydride for 5 min
(16, 17). Postembedding immunocytochemistry was by a
modification of the method described by Varndell and Polak
(18). Preparation of glutamate antiserum was similar to that
described by Storm-Mathisen et al. (19): the antiserum was
raised in rabbits against glutamate conjugated to keyhole
limpet hemocyanin with glutaraldehyde and it was charac-
terized by immunocytochemistry and immunoabsorption
(20). SP antiserum, kindly supplied by P. Petrusz (University
of North Carolina), was raised in rabbits against SP conju-
gated to keyhole limpet hemocyanin with glutaraldehyde.
Characterization of this antiserum is incomplete, but prelim-
inary results allow the exclusion of cross-reactivity with
neurokinin A (L. Abdullah and P. Petrusz, personal commu-
nication). Single immunostaining was first performed to
determine the optimal dilution of each antibody (1:15,000 for
glutamate and 1:10,000 for SP). The primary antibodies were
revealed by using colloidal gold particles (10-nm diameter,
Janssen Life Sciences Products, Beerse, Belgium; 20-nm
diameter, E-Y Laboratories, San Mateo, CA) coated with
goat anti-rabbit IgG. Incubation time for both antisera and for
goat anti-rabbit IgG gold probes was 1 hr at room tempera-
ture. Double-labeling was performed according to the method
ofWang and Larsson (21). Since both antisera were raised in
rabbits, after the first cycle of immunostaining (SP antiserum
Abbreviations: DRG, dorsal root ganglion; LGV, large granular
vesicles; SP, substance P.
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and 10-nm gold IgG) free anti-IgG binding sites were dena-
tured by hot paraformaldehyde vapors. The grids were then
incubated in the glutamate antiserum and in a gold probe of
20 nm. Immunocytochemical controls included omission of
the primary antisera, replacement of one or both of the
primary antisera by normal rabbit serum or by a buffer
solution, incubation with colloidal gold alone, and incubation
with primary antisera preabsorbed with an excess of the
appropriate antigen. Nonspecific staining was very low in all
the control sections. No differences in the straining pattern
were observed when the sequence in which the antibodies
and the gold probes were applied to the section was varied.
No immunostaining was present in sections that had been
treated with hot paraformaldehyde vapors after incubation in
the primary antiserum to test the efficacy of thermal dena-
turation.
To verify the origin of immunopositive terminals, primary
afferent endings were identified by either anterograde degen-
eration or transport. In two rats, C5 dorsal root was sectioned
extradurally on the left side. After 24 or 36 hr, the animals
were perfused as described above and Vibratome sections
from C5 spinal segments were wafer-embedded in Epon. In
five rats, a 2% solution of wheat germ agglutinin-horseradish
peroxidase conjugate was injected in two to four consecutive
cervical DRGs (C4-C7). Injection volume ranged from 0.1 to
0.5 Ag per ganglion and the survival time was between 22 and
42 hr. These rats were perfused with 2.5% glutaraldehyde and
0.5% paraformaldehyde in phosphate buffer. Fifty-microm-
eter-thick Vibratome sections were cut from one or two
cervical segments (C5 and C6) and the horseradish peroxi-
dase reaction product was histochemically visualized with
the p-phenylenediamine/pyrocatechol mixture (22). Sections
were inspected under light microscope for the successful
visualization of the anterograde labeling and then wafer-
embedded. Thin sections from the superficial dorsal horn of
the two groups of animals were then processed for the
immunocytochemical localization of glutamate and SP as
described above.
RESULTS
With the immunocytochemical procedure used here, termi-
nals labeled by the glutamate and SP antiserum are identified
by the presence of large and small gold particles, respec-
tively. Terminals labeled by both antisera are identified by
the presence of particles of both sizes. In the same thin
section, single- and double-labeled terminals are present
amidst unlabeled ones. In terminals immunoreactive for
glutamate, gold particles are randomly distributed over the
axoplasm (Fig. 1 A and B). Glutamate-labeled terminals in
lamina I are mainly small dome-shaped and make asymmetric
synapses in the plane of the section on a single dendrite. They
contain many round, small, clear vesicles and, in many
instances, a variable number of large granular vesicles
(LGV). Glutamate-positive terminals of the same type are
also numerous in the outer portion of lamina II where they
were intermingled with larger scalloped terminals of two
types. One type has dark axoplasm, densely packed clear
vesicles of various size, and few LGV and mitochondria;
these terminals are often arranged in rows and make asym-
metric contacts in the plane of the section with several
different profiles, some also containing vesicles (Fig. LA).
The other type has light axoplasm, uniformly small clear
vesicles, and many mitochondria; these terminals may con-
tain neurofilaments and make asymmetric contacts with
fewer elements than the dark scalloped terminals (Fig. 1B).
The light scalloped terminals predominate in the ventral part
of inner lamina II, while dark scalloped terminals are mainly
present more dorsally in the same lamina.
SP labeling is characterized by the presence of gold
particles over LGV in numerous dome-shaped and dark
scalloped terminals; light scalloped terminals are not SP
positive. SP-positive terminals also contain unlabeled LGV
and many small clear vesicles; labeled LGV are often located
away from the synaptic zone (Fig. 1 C-E). Labeled LGV are
also in varicosities without synaptic specializations in the
plane of the section and in small myelinated or unmyelinated
axonal profiles. While the origin of dome-shaped terminals
may be varied, scalloped terminals in lamina II have mor-
phological characteristics ofprimary afferent terminals form-
ing the central element of typical synaptic glomeruli in this
lamina (23). Scalloped terminals may belong to two different
functional classes according to whether they have a light or
dark axoplasm (see Discussion). In the present material, the
light scalloped type is only labeled by glutamate, while the
dark scalloped type can be either single-labeled by glutamate
or double-labeled-i.e., by glutamate and SP (Fig. 1 C-E). Of
450 boutons of the dark scalloped type in lamina II, 314 (70%6)
are immunopositive for glutamate, 68 (15%) are labeled with
both glutamate and SP, and none is single-labeled with SP. In
all double-labeled terminals, the two antigens are in different
cellular compartments (Fig. 1 C-E): as in single-labeled
terminals, SP immunoreactivity is mainly associated with
LGV, while glutamate is throughout the axoplasm. Since
LGV may not be uniformly distributed within one terminal,
the percentage of double-labeled terminals might be actually
higher than suggested by the examination of samples from
isolated sections. However, a bouton single-labeled in one
section did not display the second label or double-labeling
even when followed by several serial sections. Terminals
containing flattened vesicles are never labeled with either
antiserum.
The primary afferent origin of immunopositive terminals
could be documented in rats with rhizotomy (Fig. 2 A and B)
or DRG injections (Fig. 2C). In these rats, anterograde
labeling was present in scalloped terminals and in some
dome-shaped terminals but not in other types of endings.
Endings readily recognizable as labeled by either degenera-
tion or lectin transport tended to display weaker immuno-
cytochemical labeling than terminals at earlier stages of
degeneration or with relatively faint histochemical reaction
products. As a result of this, no attempt was made to gather
quantitative data on immunocytochemical labeling of identi-
fied primary afferent terminals. In general, primary afferent
terminals only positive for SP were more easily found in rats
subjected to rhizotomy than in rats with DRG injections of
tracer. Numerous primary afferent terminals only positive for
glutamate were found in both groups of animals. Primary
afferent endings labeled for both SP and glutamate, of the
dark scalloped type in lamina II, were observed after rhizot-
omy (Fig. 2 A and B) and after tracer injections (Fig. 2C).
DISCUSSION
Immunostaining with the glutamate antiserum used here is
selective in that (i) not all terminals are labeled, (ii) labeled
terminals have morphological features associated with the
release of an excitatory transmitter, and (iii) terminals
containing flattened vesicles, usually associated with the
presence of an inhibitory transmitter, especially y-aminobu-
tyric acid, are not labeled. Similar selective staining in
superficial laminae of the medullary dorsal horn was previ-
ously shown by preembedding immunocytochemistry with
the same glutamate antiserum used here (24). The likelihood
that this selectivity is related to a neurotransmitter pool
rather than a metabolic pool has been discussed in previous
publications (24, 25). Although the possibility remains open
that the immunocytochemical label may correlate with high
levels of oligopeptides, or neuroactive substances other than
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FIG. 1. (A and B) Scalloped glutamate-labeled (20-nm gold particles) terminals in lamina II of rat dorsal horn. (A) Dark type with densely
packed round clear vesicles of varied size and sparse mitochondria; each one of these terminals may make synaptic contacts with several
dendrites in the plane of the section (arrowheads). (B) Light type with sparser vesicles uniform in size and with several mitochondria. (C-E)
Dark scalloped terminals in lamina II double-labeled by glutamate (large gold particles) and by SP (10-nm gold particles) antisera. Glutamate
immunoreactivity is scattered in the axoplasm. SP immunoreactivity is mostly over LGV (arrows), but not all LGV are labeled (arrowheads).
(Bars = 0.5 ALm.)
glutamate, glutamergic transmission in DRG neurons has been
proposed by several lines of evidence summarized in the
Introduction. Furthermore, a high concentration of binding
sites for glutamate and for N-methyl-D-aspartate-type receptors
has been reported in superficial laminae of the dorsal horn (26,
27). Therefore, the selective staining of synaptic terminals with
the glutamate antiserum is taken as strongly suggestive of a
neurotransmitter role for glutamate in the labeled terminals. SP
labeling in the superficial laminae of the dorsal horn as reported
here is similar to that previously obtained with preembedding
immunocytochemistry using different SP antigens (11, 28). With
regard to cellular localization of SP, the colloidal gold postem-
bedding method allows better assessment of the virtually
exclusive association of the peptide with LGV than has been
possible in the central nervous system using other immuno-
cytochemical methods.
e^..:n.so ..s - .. , . :1C
4 Or t hi









*, *. f S:* .3>. illiiis 0 .
hi.- 9, J t;<t. r
t ^-̂ .,sj;4.
. of 4
_ _ wP ^L
C
Proc. Natl. Acad. Sci. USA 85 (1988)
.4











Proc. Natl. Acad. Sci. USA 85 (1988) 7823
13~~~~~~~~.
;-Is--4 ; - wBE'W
- * 0
A=]_~ ~-b .






FIG. 2. Primary afferent terminals of the dark scalloped type immunopositive for glutamate (20-nm gold particles) and for SP (10-nm gold
particles; arrows). (A) Early stage of degeneration characterized by the presence of an osmiophilic body (arrowhead) and clustering of synaptic
vesicles. (B) Later stage of degeneration characterized by increased electron density of the axoplasm and shrinkage of the terminal. (C)
Electron-dense horseradish peroxidase reaction product (arrow) after injection of wheat germ agglutinin-horseradish peroxidase in the DRG.
(Bars = 0.5 gm.)
The majority of primary afferent terminals in lamina II of
the spinal cord, identified here by rhizotomy or anterograde
transport, are of the scalloped type: among these terminals
the light type is believed to belong to myelinated fibers and
the dark type to unmyelinated (C) and small myelinated (A8)
fibers (29, 30). Both types are glutamate immunopositive, in
parallel with the light microscopic observation that both large
and small neurons in the DRGs are glutamate immunoposi-
tive (15). Primary afferents mediating impulses to the dorsal
horn from several different peripheral receptor classes may
thus be glutamergic. The present results suggest a role for
glutamate in nociception since dark scalloped terminals (from
AS and C fibers) are glutamate immunopositive; this conclu-
sion is in keeping with the fact that excitation of spinal
neurons by AS and C fibers is blocked by antagonists of
amino acid receptors (31, 32). Evidence from iontophoretic
release of glutamate in spinal cord slices also suggests that
glutamate is the neurotransmitter for nociceptive afferents
(33). The coexistence of SP in a fraction of terminals of the
same type also argues in favor of glutamergic transmission in
nociceptive afferents since this peptide has long been asso-
ciated with afferents mediating noxious stimuli (34).
Previous electrophysiological studies both in vivo and in
vitro have suggested that the synaptic release of SP may
function as modulator of the excitatory effects of glutamate
(35, 36). The present results provide evidence that favors the
possibility of a co-release of these two neuromediators from
the same primary afferent terminal.
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